Characterization of the binding of a novel radioligand to CCK(B)/gastrin receptors in membranes from rat cerebral cortex

British Journal of Pharmacology

Volumn 126, Issue 6, 1999, Pages 1504-1512

  Harper, E A ^a   Shankley, N P ^a   Black, J W ^a  

^a James Black Foundation   (United Kingdom)

Author keywords

Cholecystokinin; Gastrin; Rat cortex; Receptor; 3H JB93182

Indexed keywords

5 [[[[(3,5 DICARBOXYPHENYL)AMINO]CARBONYL] 2 PHENYLETHYLAMINO]CARBONYL] 6 [[(1 ADAMANTYLMETHYL)AMINO]CARBONYL]INDOLE; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; DEVAZEPIDE; GASTRIN RECEPTOR; LINTITRIPT; RADIOLIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG SELECTIVITY; ISOTOPE LABELING; LIGAND BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0033066672     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702447     Document Type: Article

References (51)

1. BEINBORN, M., LEE, Y-M, MCBRIDE, E.W., QUINN, S.M. & KOPIN, A.S. (1993). A single amino acid of the cholecystokinin-β/gastrin receptor determines specificity for non-peptide antagonists. Nature, 362, 348-350.
2. BERTRAND, P., BOHME, G.A., DURIEUX, C., GUYON, C., CAPET, M., JEANTAUD, B., BOUDEAU, P., DUCOS, B., PENDLEY, C.E., MARTIN, G.E., FLOCH, A. & DOBLE, A. (1994). Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKβ/gastrin receptor antagonists. Eur. J. Pharmacol., 262, 233-245.
3. 3H]-L-365,260: A potent and selective brain cholecystokinin (CCK-β) and gastrin receptor antagonist radioligand. Mol. Pharmacol., 35, 803-808.
4. 3H]-pentagastrin binding sites in guinea-pig gastric glands-an alternative convenient ligand for receptor binding assays. Biochem. Biophys. Res. Commun., 134, 895-899.
5. 50 of an enzymic reaction. Biochem. Pharmacol., 22, 3099-3108.
6. CHILDERS, S.R. & LARIVIERE, G. (1984). Modification of guanine nucleotide-regulatory components in brain membranes. II Relationship of guanosine 5′-triphosphate effects on opiate receptor binding and coupling receptors with adenylate cyclase. J. Neurosci., 4, 2764-2771.
7. CITRI, Y. & SCHRAMM, M. (1980). Resolution, reconstitution and kinetics of the primary action of a hormone receptor. Nature, 287, 297- 300.
8. CLARKE, C.R., DAUM, P. & HUGHES, J. (1986). A study of the cerebral cortex cholecystokinin receptor using two radiolabelled probes: evidence for a common CCK8 and CCK4 cholecystokinin receptor binding site. J. Neurochem., 46, 1094-1101.
9. 8 analogues. Biochem. Biophys. Res. Commun., 154, 1301-1307.
10. 3H]-SNF 8702. Mol. Pharmacol., 42, 1089-1095.
11. GALLEYRAND, J.C., LIMA-LEITE, A.C., LALLEMENT, J.C., LIGNON, M.F., BERNAD, N., FULCRAND, P. & MARTINEZ, J. (1994). Synthesis and characterisation of a new labeled gastrin ligand, [{sTXT} 125{XTXT}I]-BH-[leu 15]-gastrin-(5-17), on binding to canine fundic mucosal cells and Jurkat cells. Int. J. Peptide Protein Res., 44, 348-358.
12. Α receptors. Eur. J. Pharmacol., 232, 13-19.
13. 3H-dopamine binding to rat striatal D-2 and D-3 sites: enhancement by magnesium and inhibition by guanine nucleotides and sodium. Life Sci., 30, 1587-1595.
14. β/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex. Br. J. Pharmacol., 126, 1375-1382.
15. β/gastrin receptor antagonist (JB93182) in mouse and rat cerebral cortex and guinea-pig pancreas. Br. J. Pharmacol., 117, 287P.
16. HARPER, E.A., SHANKLEY, N.P. & BLACK, J.W. (1996a). Analysis of variation in L-365,260 competition curves in radioligand binding assays. Br. J. Pharmacol., 118, 1717-1726.
17. β/gastrin receptors in rat cerebral cortical membranes. Br. J. Pharmacol., 117, 286P.
18. HUGHES, J., BODEN, P.R., COSTALL, B., DOMENEY, A., KELLY, E., HORWELL, D.C., HUNTER, J.C., PINNOCK, R.D. & WOODRUFF, G.N. (1990). Development of a class of selective cholecystokinin type B receptor antagonists having a potent anxiolytic activity. Proc. Natl. Acad. Sci. U.S.A., 87, 6728 6732.
19. Α receptor antagonist. Br. J. Pharmacol., 108, 734-740.
20. β/gastrin receptor in guinea-pig cerebral cortex and gastric mucosa. Mol. Pharmacol., 43, 595- 602.
21. INOMOTO, Y., KINOSHITA, Y., NAKAMURA, A., ARIMA, N., YAMASHITA, Y., NAKATA, H., YAMAMURA, Y., HOSODA, S. & CHIBA, T. (1993). Characterisation of gastrin/CCK receptors on gastric carcinoid tumor membrane of Mastomys natalensis. Reg. Peptides, 43, 149-158.
22. INSEL, P.A., MAHAN, L.C., MOTULSKY, H.J., STOOLMAN, L.M. & KOACHMAN, A.M. (1983). Time-dependent decreases in binding affinity of agonists for β-adrenergic receptors on intact S49 lymphoma cells. A mechanism of desensitisation. J. Biol. Chem., 258, 13597-13605.
23. INSEL,P.A. & SANDA, M. (1983). Temperature-dependent changes in the binding to β-adrenergic receptors of intact S49 lymphoma cells. J. Biol. Chem., 254, 6554-6559.
24. ITO, M., IWATA, N., TANIGUCHI, T., MURAYAMA, T., CHICARA, K. & MATSUI, T. (1994). Functional characterisation of two cholecystokinin-β/gastrin receptor isoforms: A preferential splice donor site in the human receptor gene. Cell Growth Differentiation, 5, 1127- 1135.
25. β/gastrin receptors. Bioorgan. Med. Chem. Lett., 6, 1171-1174.
26. KENT, R.S., DELEAN, A. & LEFKOWITZ, R.J. (1979). A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modelling of ligand binding data. Mol. Pharmacol., 17, 14 23.
27. KIM, M.H., & NEUBIG, R.R. (1985). Parallel inactivation of α-adrenergic agonist binding and Ni by alkaline treatment. FEBS Letts., 192, 321-325.
28. KOSTERLITZ, H., PATERSON, S. & ROBSON, L. (1988). Modulation of the binding at opioid receptors by mono- and divalent cations and by cholinergic compounds. J. Recept. Res., 8, 363-373.
29. LEATHERBARROW, J. (1987). ENZFITTER. A non-linear regression data analysis program for the IBM Pc. Biosoft.
30. LIGNON, M-F., BERNAD, N. & MARTINEZ, J. (1991). Pharmacological characterisation of type B cholecystokinin binding sites on human JURKAT T lymphocyte cell line. Mol. Pharmacol., 39, 615-620.
31. 2 adrenergic receptor in membrane and solubilised preparations. Mol. Pharmacol., 21, 609-617.
32. LOTTI, V.L. & CHANG, R.S.L. (1989). A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-β) ligand: L-365,260. Eur. J. Pharmacol., 162, 273-280.
33. MINUTH, M. & JAKOBS, K. (1986). Sodium regulation of agonist and antagonist binding to beta-adrenoceptors in intact and Ns deficient membranes. Naunyn-Scmeidebergs Arch. Pharmacol., 33, 124- 129.
34. MUNSON, P.J. & RODBARD, D. (1980). LIGAND: a versatile computerised approach for characterisation of ligand-binding systems. Anal. Biochem., 107, 220-239.
35. 2 adenosine receptor: Guanine nucleotide modulation of agonist binding is enhanced by proteolysis. Mol. Pharmacol., 39, 130-135.
36. 1 adenosine receptor/G protein coupling: Identification of a membranes protein that stabilises the association of the receptor/G protein complex. Mol. Pharmacol., 48, 806-817.
37. NISHIDA, A., MIYATA, K., TSUTSUMI, R., YUKI, H., AKUZAWA, S., KOBAYASHI, A., KAMATO, T., ITO, H., YAMANO, M., KATUYAMA, Y., SATOH, M., OHTA, M. & HONDA, K. (1994). Pharmacological profile of (R)-1-[2,3-dihydro-1-(2′-methyl-phenacyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022(, a new potent and selective gastrin/cholecystokinin- β receptor antagonist, in Vitro and in Vivo. J. Pharmacol. Exp. Ther., 269, 725-731.
38. 2 receptors: a quantitative autoradiographical study. Mol. Neuropharmacol., 1, 179-186.
39. PATERSON, S.J., ROBSON, L.E., KOSTERLITZ, H.W. (1986). Control by cations of opioid binding in guinea-pig brain membranes. Proc. Natl. Acad. Sci. U.S.A., 83, 6216-6220.
40. PERT, C.B. & SNYDER, S.H. (1974). Opiate receptor binding of agonists and antagonists affected differentially by sodium. Mol. Pharmacol., 10, 868-879.
41. 8 to guinea-pig fundic gastric glands differ: is there more than one binding site for peptides of the CCK-gastrin family. Biochem. Biophys. Res. Commun., 123, 641-647.
42. RAMANI, N. & PRAISSMAN, M. (1989). Molecular identification and characterisation of the gastrin receptor in guinea-pig gastric glands. Endocrinol., 124, 1881-1887.
43. β/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assays. Br. J. Pharmacol., 118, 1779- 1789.
44. β/gastrin receptor antagonist in isolated stomach preparations of immature rat, mouse and guinea-pig. FASEB J., A2199.
45. SHANKLEY, N.P., ROBERTS, S.P., WATT, G.F., KOTECHA, A., HULL, R. & BLACK, J.W. (1997). Analysis of the complex pharmacology expressed by the CCK-β/gastrin ligand PD134,308 on gastric assays. ASPET Pharmacol., 39, P65.
46. SLADECZEK, F., BOCKAERT, J. & MAUGER, J-P. (1983). Differences between agonist and antagonist binding to alpha-adrenergic receptors of intact and broken cell preparations. Mol. Pharmacol., 24, 392-397.
47. 2+ mobilisation. Eur. J. Pharmacol., 267, 215-223.
48. UNDEN, A. & BARTFAI, T. (1984). regulation of neuropeptide Y (NPY) binding by guanine nucleotides in the rat cerebral cortex. FEBS Lett., 177, 125-128.
49. 3H]-cholecystokinin as radioligand. J. Neurosci., 4, 1021-1033.
50. WEILAND, G.A. & MOLINOFF, P.B. (1981). Quantitative analysis of drug-receptor interactions. I. Determination of kinetic and equilibrium properties. Life Sci., 29, 313-330.
51. WERLING, L.L., BROWN, S.R., PUTTFARCKEN, P. & COX, B.M. (1986). sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea-pig cortical membranes. Mol. Pharmacol., 30, 90-95.